Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

HMS faculty, help us improve the algorithms in Profiles by uploading your CV!

Tomohisa Matsunaga, M.D.

Title
Institution
Department
Address

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Schroeter A, Roesel MJ, Matsunaga T, Xiao Y, Zhou H, Tullius SG. Aging Affects the Role of Myeloid-Derived Suppressor Cells in Alloimmunity. Front Immunol. 2022; 13:917972. PMID: 35874716; PMCID: PMC9296838.
    Citations:    Fields:    Translation:HumansCells
  2. Maenosono R, Fukushima T, Kobayashi D, Matsunaga T, Yano Y, Taniguchi S, Fujiwara Y, Komura K, Uehara H, Kagitani M, Hirano H, Inamoto T, Nomi H, Azuma H. Unplanned hemodialysis initiation and low geriatric nutritional risk index scores are associated with end-stage renal disease outcomes. Sci Rep. 2022 06 30; 12(1):11101. PMID: 35773447; PMCID: PMC9246913.
    Citations:    Fields:    Translation:Humans
  3. Roesel MJ, Sharma NS, Schroeter A, Matsunaga T, Xiao Y, Zhou H, Tullius SG. Primary Graft Dysfunction: The Role of Aging in Lung Ischemia-Reperfusion Injury. Front Immunol. 2022; 13:891564. PMID: 35686120; PMCID: PMC9170999.
    Citations:    Fields:    Translation:Humans
  4. Uchimoto T, Nakamura K, Komura K, Fukuokaya W, Yano Y, Nishimura K, Kinoshita S, Nishio K, Fukushima T, Nakamori K, Matsunaga T, Tsutsumi T, Tsujino T, Taniguchi K, Tanaka T, Uehara H, Takahara K, Inamoto T, Kimura T, Egawa S, Azuma H. Prognostic value of the fluctuation in the neutrophil-lymphocyte ratio at 6 weeks of pembrolizumab treatment is specific to the clinical response in metastatic urothelial carcinoma. Urol Oncol. 2022 07; 40(7):344.e11-344.e17. PMID: 35346572.
    Citations:    Fields:    Translation:HumansCells
  5. Nishimura K, Nishio K, Hirosuna K, Komura K, Hayashi T, Fukuokaya W, Ura A, Uchimoto T, Nakamura K, Fukushima T, Yano Y, Takahashi N, Nakamori K, Kinoshita S, Matsunaga T, Tsutsumi T, Tsujino T, Taniguchi K, Tanaka T, Uehara H, Takahara K, Inamoto T, Hirose Y, Kimura T, Egawa S, Azuma H. Efficacy of pembrolizumab and comprehensive CD274/PD-L1 profiles in patients previously treated with chemoradiation therapy as radical treatment in bladder cancer. J Immunother Cancer. 2022 01; 10(1). PMID: 35039462; PMCID: PMC8765067.
    Citations:    Fields:    Translation:Humans
  6. Roesel MJ, Matsunaga T, Tullius SG. Opportunities and Challenges of Targeting an Aging Immune System. Transplantation. 2021 12 01; 105(12):2515-2516. PMID: 34818306; PMCID: PMC9393903.
    Citations: 2     Fields:    
  7. Quante M, Iske J, Uehara H, Minami K, Nian Y, Maenosono R, Matsunaga T, Liu Y, Azuma H, Perkins D, Alegre ML, Zhou H, Elkhal A, Tullius SG. Taurodeoxycholic acid and valine reverse obesity-associated augmented alloimmune responses and prolong allograft survival. Am J Transplant. 2022 02; 22(2):402-413. PMID: 34551205.
    Citations: 1     Fields:    Translation:HumansAnimals
  8. Matsunaga T, Iske J, Schroeter A, Azuma H, Zhou H, Tullius SG. The potential of Senolytics in transplantation. Mech Ageing Dev. 2021 12; 200:111582. PMID: 34606875.
    Citations: 1     Fields:    Translation:Humans
  9. Komura K, Inamoto T, Tsujino T, Matsui Y, Konuma T, Nishimura K, Uchimoto T, Tsutsumi T, Matsunaga T, Maenosono R, Yoshikawa Y, Taniguchi K, Tanaka T, Uehara H, Hirata K, Hirano H, Nomi H, Hirose Y, Ono F, Azuma H. Increased BUB1B/BUBR1 expression contributes to aberrant DNA repair activity leading to resistance to DNA-damaging agents. Oncogene. 2021 10; 40(43):6210-6222. PMID: 34545188.
    Citations: 4     Fields:    Translation:HumansAnimalsCells
  10. Maenosono R, Matsunaga T, Yoshikawa Y, Nishimura K, Onaka H, Komura K, Uehara H, Azuma H. Hemodialysis Initiation in Oldest-Old Patients: A Case Series. Case Rep Nephrol Dial. 2021 Sep-Dec; 11(3):286-291. PMID: 34722647; PMCID: PMC8543281.
    Citations:    
  11. Uchimoto T, Komura K, Fukuokaya W, Kimura T, Takahashi K, Yano Y, Nishimura K, Nakamori K, Fujiwara Y, Matsunaga T, Tsutsumi T, Tsujino T, Maenosono R, Yoshikawa Y, Taniguchi K, Tanaka T, Uehara H, Hirano H, Nomi H, Takahara K, Inamoto T, Egawa S, Azuma H. Risk Classification for Overall Survival by the Neutrophil-Lymphocyte Ratio and the Number of Metastatic Sites in Patients Treated with Pembrolizumab-A Multicenter Collaborative Study in Japan. Cancers (Basel). 2021 Jul 15; 13(14). PMID: 34298768.
    Citations: 2     
  12. Quante M, Iske J, Heinbokel T, Desai BN, Cetina Biefer HR, Nian Y, Krenzien F, Matsunaga T, Uehara H, Maenosono R, Azuma H, Pratschke J, Falk CS, Lo T, Sheu E, Tavakkoli A, Abdi R, Perkins D, Alegre ML, Banks AS, Zhou H, Elkhal A, Tullius SG. Restored TDCA and valine levels imitate the effects of bariatric surgery. Elife. 2021 06 22; 10. PMID: 34155969.
    Citations:    Fields:    Translation:Animals
  13. Iske J, Matsunaga T, Zhou H, Tullius SG. Donor and Recipient Age-Mismatches: The Potential of Transferring Senescence. Front Immunol. 2021; 12:671479. PMID: 33995411; PMCID: PMC8113632.
    Citations:    Fields:    Translation:HumansAnimals
  14. Tsutsumi T, Komura K, Hashimoto T, Muraoka R, Satake N, Matsunaga T, Tsujino T, Yoshikawa Y, Takai T, Minami K, Taniguchi K, Tanaka T, Uehara H, Hirano H, Nomi H, Ibuki N, Takahara K, Inamoto T, Ohno Y, Azuma H. Distinct effect of body mass index by sex as a prognostic factor in localized renal cell carcinoma treated with nephrectomy ~ data from a multi-institutional study in Japan ~. BMC Cancer. 2021 Feb 27; 21(1):201. PMID: 33639880; PMCID: PMC7913463.
    Citations:    Fields:    Translation:Humans
  15. Uchimoto T, Komura K, Fukuokaya W, Kimura T, Takahashi K, Nishimura K, Nakamori K, Fujiwara Y, Matsunaga T, Tsutsumi T, Tsujino T, Maenosono R, Yoshikawa Y, Taniguchi K, Tanaka T, Uehara H, Ibuki N, Hirano H, Nomi H, Takahara K, Inamoto T, Egawa S, Azuma H. Early Prostate-Specific Antigen (PSA) Change at Four Weeks of the First-Line Treatment Using Abiraterone and Enzalutamide Could Predict Early/Primary Resistance in Metastatic Castration-Resistant Prostate Cancer. Cancers (Basel). 2021 Jan 30; 13(3). PMID: 33573172.
    Citations: 1     
  16. Matsunaga T, Azuma H, Tullius SG. Immunosuppression in vascularized composite allotransplant: the search for an effective and safe treatment continues. Transpl Int. 2020 10; 33(10):1291-1293. PMID: 32348589.
    Citations:    Fields:    Translation:AnimalsCells
  17. Uchimoto T, Komura K, Fukuokaya W, Kimura T, Takahashi K, Fujiwara Y, Matsunaga T, Tsutsumi T, Tsujino T, Maenosono R, Yoshikawa Y, Taniguchi K, Tanaka T, Uehara H, Ibuki N, Hirano H, Nomi H, Takahara K, Inamoto T, Egawa S, Azuma H. Risk stratification for the prediction of overall survival could assist treatment decision-making at diagnosis of castration-resistant prostate cancer: a multicentre collaborative study in Japan. BJU Int. 2021 02; 127(2):212-221. PMID: 32701219.
    Citations:    Fields:    Translation:Humans
  18. Maenosono R, Matsunaga T, Hirano H, Nomi H, Taniguchi S, Fujiwara Y, Minami K, Uehara H, Inamoto T, Azuma H. Effectiveness of Factor XIII Infusion in Treatment of Refractory Ureteral Leakage after Kidney Transplantation. Case Rep Transplant. 2020; 2020:1780760. PMID: 32724697; PMCID: PMC7381963.
    Citations:    
  19. Matsunaga T, Hirano H, Maenosono R, Tsutsumi T, Tsujino T, Yoshikawa Y, Takai T, Minami K, Uehara H, Komura K, Nomi H, Ibuki N, Inamoto T, Azuma H. Successful Treatment of Antibody-Mediated Rejection by De Novo Donor Specific Antibody After Primary Renal Transplantation in a Recipient From a Cadaveric Donor: A Case Report. Transplant Proc. 2020 Jul - Aug; 52(6):1928-1930. PMID: 32444119.
    Citations:    Fields:    Translation:Humans
  20. Matsunaga T, Komura K, Hashimoto T, Muraoka R, Satake N, Tsutsumi T, Tsujino T, Yoshikawa Y, Takai T, Minami K, Taniguchi K, Tanaka T, Uehara H, Hirano H, Nomi H, Ibuki N, Takahara K, Inamoto T, Ohno Y, Azuma H. Adjuvant chemotherapy improves overall survival in patients with localized upper tract urothelial carcinoma harboring pathologic vascular invasion: a propensity score-matched analysis of multi-institutional cohort. World J Urol. 2020 Dec; 38(12):3183-3190. PMID: 32065276.
    Citations:    Fields:    Translation:Humans
  21. Uchimoto T, Komura K, Fujiwara Y, Saito K, Tanda N, Matsunaga T, Ichihashi A, Tsutsumi T, Tsujino T, Yoshikawa Y, Nishimoto Y, Takai T, Minami K, Taniguchi K, Tanaka T, Uehara H, Hirano H, Nomi H, Ibuki N, Takahara K, Inamoto T, Azuma H. Prognostic impact of C-reactive protein-albumin ratio for the lethality in castration-resistant prostate cancer. Med Oncol. 2019 Nov 21; 37(1):9. PMID: 31754918.
    Citations: 4     Fields:    Translation:Humans
  22. Komura K, Fujiwara Y, Uchimoto T, Saito K, Tanda N, Matsunaga T, Ichihashi A, Tsutsumi T, Tsujino T, Yoshikawa Y, Nishimoto Y, Takai T, Minami K, Taniguchi K, Tanaka T, Uehara H, Hirano H, Nomi H, Ibuki N, Takahara K, Inamoto T, Azuma H. Comparison of Radiographic Progression-Free Survival and PSA Response on Sequential Treatment Using Abiraterone and Enzalutamide for Newly Diagnosed Castration-Resistant Prostate Cancer: A Propensity Score Matched Analysis from Multicenter Cohort. J Clin Med. 2019 Aug 19; 8(8). PMID: 31430900; PMCID: PMC6723570.
    Citations: 3     
  23. Komura K, Hashimoto T, Tsujino T, Muraoka R, Tsutsumi T, Satake N, Matsunaga T, Yoshikawa Y, Takai T, Minami K, Taniguchi K, Uehara H, Tanaka T, Hirano H, Nomi H, Ibuki N, Takahara K, Inamoto T, Ohno Y, Azuma H. The CANLPH Score, an Integrative Model of Systemic Inflammation and Nutrition Status (SINS), Predicts Clinical Outcomes After Surgery in Renal Cell Carcinoma: Data From a Multicenter Cohort in Japan. Ann Surg Oncol. 2019 Sep; 26(9):2994-3004. PMID: 31240592.
    Citations: 5     Fields:    Translation:HumansCells
  24. Tsujino T, Komura K, Hashimoto T, Muraoka R, Satake N, Matsunaga T, Tsutsumi T, Yoshikawa Y, Takai T, Minami K, Uehara H, Hirano H, Nomi H, Ibuki N, Takahara K, Inamoto T, Ohno Y, Azuma H. C-reactive protein-albumin ratio as a prognostic factor in renal cell carcinoma - A data from multi-institutional study in Japan. Urol Oncol. 2019 11; 37(11):812.e1-812.e8. PMID: 31053528.
    Citations: 15     Fields:    Translation:Humans
  25. Tsujino T, Komura K, Ichihashi A, Tsutsumi T, Matsunaga T, Yoshikawa Y, Maenosono R, Okita K, Takai T, Oide R, Minami K, Uehara H, Taniguchi K, Hirano H, Nomi H, Ibuki N, Takahara K, Inamoto T, Azuma H. The combination of preoperative platelet count and neutrophil lymphocyte ratio as a prognostic indicator in localized renal cell carcinoma. Oncotarget. 2017 Dec 15; 8(66):110311-110325. PMID: 29299149; PMCID: PMC5746384.
    Citations: 6     Fields:    
  26. Tsujino T, Komura K, Matsunaga T, Yoshikawa Y, Takai T, Uchimoto T, Saito K, Tanda N, Oide R, Minami K, Uehara H, Jeong SH, Taniguchi K, Hirano H, Nomi H, Ibuki N, Takahara K, Inamoto T, Azuma H. Preoperative Measurement of the Modified Glasgow Prognostic Score Predicts Patient Survival in Non-Metastatic Renal Cell Carcinoma Prior to Nephrectomy. Ann Surg Oncol. 2017 Sep; 24(9):2787-2793. PMID: 28643013.
    Citations: 12     Fields:    Translation:Humans
  27. Tsujino T, Takahara K, Matsunaga T, Yoshikawa Y, Takai T, Uchimoto T, Saito K, Tanda N, Hirano H, Nomi H, Ibuki N, Inamoto T, Azuma H. Remarkable response to fluorouracil, leucovorin, oxaliplatin, and irinotecan therapy in urothelial cancer of the renal pelvis: a case report. J Med Case Rep. 2017 Apr 10; 11(1):99. PMID: 28391777.
    Citations:    Fields:    Translation:Humans
  28. Takai T, Inamoto T, Komura K, Tsujino T, Matsunaga T, Yoshikawa Y, Uchimoto T, Saito K, Tanda N, Minami K, Uehara H, Ibuki N, Takahara K, Nomi H, Kiyama S, Azuma H. Prostatic Bleeding after Prostatic Biopsy Effects Oncological Outcomes with Laparoscopic Radical Prostatectomy. Asian Pac J Cancer Prev. 2016; 17(3):1373-7. PMID: 27039775.
    Citations:    Fields:    Translation:Humans
  29. Tsujino T, Inamoto T, Matsunaga T, Uchimoto T, Saito K, Takai T, Minami K, Takahara K, Nomi H, Azuma H. [Idiopathic Lumbar Hernia: A Case Report]. Hinyokika Kiyo. 2015 Nov; 61(11):449-53. PMID: 26699890.
    Citations: 1     Fields:    Translation:Humans
  30. Nomi H, Takahara K, Minami K, Maenosono R, Matsunaga T, Yoshikawa Y, Tsujino T, Hirano H, Inamoto T, Yamamoto I, Tsuji M, Kiyama S, Azuma H. [A CASE OF ADVANCED BLADDER NEUROENDOCRINE CARCINOMA (SMALL CELL CARCINOMA) SIGNIFICANTLY IMPROVED BY LOW DOSE OF ORAL TEGAFUR-URACIL]. Nihon Hinyokika Gakkai Zasshi. 2015 Oct; 106(4):269-73. PMID: 26717786.
    Citations:    Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Matsunaga's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (131)
Explore
_
Co-Authors (8)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.